Prelude Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-884
| Closed | -$106K | – | 1869 |
|
|
2019
Q3 | $106K | Buy |
884
+245
| +38% | +$29.4K | ﹤0.01% | 576 |
|
|
2019
Q2 | $191K | Buy |
639
+351
| +122% | +$105K | 0.01% | 474 |
|
|
2019
Q1 | $130K | Buy |
288
+7
| +2% | +$3.16K | 0.01% | 553 |
|
|
2018
Q4 | $128K | Buy |
281
+135
| +92% | +$61.5K | 0.01% | 621 |
|
|
2018
Q3 | $132K | Sell |
146
-18
| -11% | -$16.3K | 0.01% | 625 |
|
|
2018
Q2 | $97K | Buy |
+164
| New | +$97K | 0.01% | 732 |
|